AQUAVAGE Trademark

Trademark Overview


On Tuesday, January 23, 2024, a trademark application was filed for AQUAVAGE with the United States Patent and Trademark Office. The USPTO has given the AQUAVAGE trademark a serial number of 98370945. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, August 19, 2024. This trademark is owned by Summit Medical, LLC. The AQUAVAGE trademark is filed in the Medical Instrument Products category with the following description:

medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment
aquavage

General Information


Serial Number98370945
Word MarkAQUAVAGE
Filing DateTuesday, January 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesmedical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSummit Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Trademark Events


Event DateEvent Description
Friday, January 26, 2024NEW APPLICATION ENTERED
Thursday, February 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 19, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024NON-FINAL ACTION E-MAILED
Monday, August 19, 2024ASSIGNED TO EXAMINER